Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / Class A Common Stock
-
Shares outstanding
-
111,633,839
-
Total 13F shares
-
127,923,184
-
Share change
-
-1,128,439
-
Total reported value
-
$3,615,644,954
-
Put/Call ratio
-
121%
-
Price per share
-
$28.28
-
Number of holders
-
260
-
Value change
-
+$9,635,003
-
Number of buys
-
124
-
Number of sells
-
128
Institutional Holders of Evolent Health, Inc. - Class A Common Stock (EVH) as of Q3 2024
As of 30 Sep 2024,
Evolent Health, Inc. - Class A Common Stock (EVH) was held by
260 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
127,923,184 shares.
The largest 10 holders included
WELLINGTON MANAGEMENT GROUP LLP, VANGUARD GROUP INC, BlackRock, Inc., RA CAPITAL MANAGEMENT, L.P., WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC, FMR LLC, JPMORGAN CHASE & CO, Engaged Capital LLC, EVENTIDE ASSET MANAGEMENT, LLC, and Granahan Investment Management, LLC.
This page lists
255
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.